---
title: "The 8th Changbai Mountain Pharmaceutical and Health Industry Development Forum was held in Tonghua"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/252378474.md"
description: "On August 10th, the 15th Northeast Asia Expo - the 8th Changbai Mountain Pharmaceutical Health Industry Development Forum was held in Tonghua City, Jilin Province. It is understood that Tonghua, as the \"Chinese Medicine City\" and \"Hometown of Ginseng,\" has gradually formed a diversified industrial development pattern supported by modern traditional Chinese medicine, biopharmaceuticals, chemical drugs, and medical devices. This event announced the geographical indication certification trademark for \"Tonghua Ginseng,\" and signed the commissioning agreement for the compilation of the \"Tonghua Ginseng Annual Industry Development Report\" and the cooperation agreement for the Health Product R&D and Production Service Center"
datetime: "2025-08-10T11:37:48.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/252378474.md)
  - [en](https://longbridge.com/en/news/252378474.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/252378474.md)
generator: "portal-rs"
---

# The 8th Changbai Mountain Pharmaceutical and Health Industry Development Forum was held in Tonghua

On August 10th, the 15th Northeast Asia Expo - the 8th Changbai Mountain Pharmaceutical Health Industry Development Forum was held in Tonghua City, Jilin Province. It is understood that Tonghua, as the "Pharmaceutical City of China" and "Home of Ginseng in China," has gradually formed a diversified industrial development pattern supported by modern traditional Chinese medicine, biopharmaceuticals, chemical drugs, and medical devices. This event announced the geographical indication certification trademark for "Tonghua Ginseng," signed the commissioning agreement for the compilation of the "Tonghua Ginseng Annual Industry Development Report," and the cooperation agreement for the Health Product R&D and Production Service Center

### Related Stocks

- [01643.HK](https://longbridge.com/en/quote/01643.HK.md)
- [600056.CN](https://longbridge.com/en/quote/600056.CN.md)

## Related News & Research

- [Livzon Pharma buys 3.5% Xinbeijiang Pharma stake for RMB 106.7 million](https://longbridge.com/en/news/296601614.md)
- [HENGRUI PHARMA  1H26 Net Profit Rises 0.3% YoY to RMB4.465 Billion; Shares Now Down Over 7%](https://longbridge.com/en/news/296422700.md)
- [SMOORE INTL  1H26 Net Profit Up 16.2% YoY to RMB572M; Interim DPS Maintained at HKD0.2](https://longbridge.com/en/news/296421803.md)
- [CStone says China NMPA clears IND for CS5007 EGFR/HER3 bispecific ADC](https://longbridge.com/en/news/296540686.md)
- [CSPC PHARMA  Shares Rise 15% as Phase Ib/II Clinical Trial of SYS 6090 Injection for Hepatocellular Carcinoma Launches at First Center in China](https://longbridge.com/en/news/296423040.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**